Substance Withdrawal Syndrome
Information
- Disease name
- Substance Withdrawal Syndrome
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00000244 | Completed | Phase 2 | Effects of Dynorphin 1-13 on Heroin Addiction - 1 | August 1994 | March 1997 |
| NCT00000292 | Completed | Phase 1 | Acute Withdrawal From Smoked Cocaine - 9 | April 1996 | December 2001 |
| NCT00032955 | Completed | Phase 3 | Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification - 1 | February 2001 | August 2002 |
| NCT00032968 | Completed | Phase 3 | Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1 | January 2001 | August 2002 |
| NCT00114439 | Completed | Phase 2 | Lithium Cannabis Withdrawal Study | September 2005 | September 2006 |
| NCT00367874 | Completed | Phase 4 | Treatment of Polydrug-Using Opiate Dependents During Withdrawal | February 2003 | November 2003 |
| NCT00570219 | Completed | N/A | The Effect of Valproate on Benzodiazepine Withdrawal Severity | February 2005 | May 2008 |
| NCT00695864 | Completed | N/A | Effect of Ondansetron for Withdrawal Symptoms | May 2008 | July 2009 |
| NCT02825459 | Completed | N/A | Does Abstinence From E-cigarettes Produce Withdrawal Symptoms? | July 2016 | October 31, 2018 |
| NCT03374722 | Completed | Opioid Withdrawal Symptoms in Critically Ill Patients | January 1, 2018 | October 7, 2018 | |
| NCT03435614 | Completed | Signs and Symptoms of Opioid-associated Iatrogenic Withdrawal in Critically Ill Adults | February 26, 2018 | September 30, 2018 | |
| NCT00900900 | Completed | Phase 2 | The Effects of One-Time Pregnenolone, Dehydroepiandrosterone (DHEA), or Placebo Administration On Withdrawal Symptoms, Mood, Craving And Cigarette Evaluation Ratings In Male Smokers | July 2009 | March 2011 |
| NCT00980044 | Completed | Phase 2/Phase 3 | Efficacy of Extended Release Tramadol for Treating Prescription Opioid Withdrawal | October 2009 | March 2012 |
| NCT00992979 | Completed | Phase 2 | Therapeutic Massage to Manage Withdrawal Related Anxiety | June 2008 | January 2009 |
| NCT01362959 | Completed | Phase 4 | Nicotine Replacement Therapy in the Intensive Care Unit | June 2012 | August 2016 |
| NCT02108626 | Completed | Phase 4 | Electronic Cigarettes in Daily Dependent Smokers | March 2014 | April 2015 |
| NCT02318290 | Completed | Opioids Withdrawal Syndrome in Critically Ill Patients: a Multicenter Prospective Cohort Study | January 2015 | December 2015 | |
| NCT02431728 | Completed | Phase 1/Phase 2 | The Effect of Melatonin Upon Post-Acute Withdrawal Among Males in a Residential Treatment Program | May 2015 | January 2016 |
| NCT02643355 | Completed | N/A | Utility of Olanzapine in the Treatment of Opioid Withdrawal in the ED | November 2015 | June 21, 2017 |
| NCT02715440 | Completed | N/A | Stopping Benzodiazepines and Related Molecules Among Elderly Living in Residential Institutions | February 2012 | August 2015 |
| NCT02782156 | Completed | Process Evaluation Standardised Nurse-led Approach for Risk Screening and Decrease of Alcohol Withdrawal in ENT | November 2014 | June 2016 | |
| NCT02801357 | Completed | Phase 1 | Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction | June 2016 | August 2016 |
| NCT00792415 | Unknown status | Validation of a Pediatric-Specific Abstinence Syndrome Assessment Tool | November 2009 | December 2010 | |
| NCT02951793 | Unknown status | Abuse and Addiction in ICU | March 2016 | December 2022 | |
| NCT04917185 | Unknown status | N/A | EA for PAAS: A pRCT | June 2021 | December 2023 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D013375